drugset / Trial / NCT05609877

The NONA-LISA Trial

NCT05609877 ↗

Recruiting 324 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The NONA-LISA trial will be an investigator-initiated, multicentre, pragmatic, parallel-group, blinded RCT conducted at four university hospitals across Denmark. A total of 324 inborn premature infants will be included within 36 months at four neonatal intensive care units (NICUs) across Denmark (approximately 2 infants per month per unit). The aim is to compare LISA using a non-pharmacological approach alone with routine analgesic treatment combined with a non-pharmacological approach (according to local guidelines) regarding LISA failure defined as the need for positive pressure ventilation for 30 min or more (cumulated) within 24 hours after the procedure in infants born prior to 30 gestational weeks.

Timeline

Start
2024-06-01
Primary completion
2028-05-31
Completion
2029-05-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.5 ug/kg Intravenous
Comparator Fentanyl Other / unclassified 1 ug/kg Intravenous